Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Review

Clinical Trial

Randomized Controlled Trial

Research Support, N.I.H., Extramural

Comparative Study

Meta-Analysis

Controlled Clinical Trial

Research Support, N.I.H., Intramural

Multicenter Study

Systematic Review

Research Support, U.S. Gov't, P.H.S.

Research Support, U.S. Gov't, Non-P.H.S.

Validation Study

Case Reports

Evaluation Study

Clinical Trial, Phase I

Retracted Publication

Historical Article

Video-Audio Media

Scoping Review

Publication Year

From

Quick links

Individual year

2025

2024

2023

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Receptors, Dopamine D2""[mesh_terms]

84 Results

Searching titles within these results

Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia: III. Retinoids.

Anne Schock Citver, Anastasia M Shields, Lisa M Ciaccia, Robert J Schulingkamp, Robert B Raffa

Journal of clinical pharmacy and therapeutics 2003;27(3):161-8

Full Text

Abstract

Ligand with Two Modes of Interaction with the Dopamine D Receptor-An Induced-Fit Mechanism of Insurmountable Antagonism.

Richard Ågren, Hugo Zeberg, Tomasz Maciej Stępniewski, R Benjamin Free, Sean W Reilly, Robert R Luedtke, Peter Århem, Francisco Ciruela, David R Sibley, Robert H Mach, Jana Selent, Johanna Nilsson, Kristoffer Sahlholm

ACS chemical neuroscience 2021;11(19):3130-3143

Free Full Text

Abstract

Common variants in DRD2 are associated with sleep duration: the CARe consortium.

Brian E Cade, Daniel J Gottlieb, Diane S Lauderdale, David A Bennett, Aron S Buchman, Sarah G Buxbaum, Philip L De Jager, Daniel S Evans, Tibor Fülöp, Sina A Gharib, W Craig Johnson, Hyun Kim, Emma K Larkin, Seung Ku Lee, Andrew S Lim, Naresh M Punjabi, Chol Shin, Katie L Stone, Gregory J Tranah, Jia Weng, Kristine Yaffe, Phyllis C Zee, Sanjay R Patel, Xiaofeng Zhu, Susan Redline, Richa Saxena

Human molecular genetics 2016;25(1):167-79

Free Full Text

Abstract

Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome.

Walter Paulus, Claudia Trenkwalder

The Lancet. Neurology 2006;5(10):878-86

Full Text

Abstract

Selectivity of probes for PET imaging of dopamine D3 receptors.

Robert K Doot, Jacob G Dubroff, Kyle J Labban, Robert H Mach

Neuroscience letters 2019;691():18-25

Free Full Text

Abstract

Neurogenetic and Neuroimaging Evidence for a Conceptual Model of Dopaminergic Contributions to Obesity.

Ansley Grimes Stanfill, Yvette Conley, Ann Cashion, Carol Thompson, Ramin Homayouni, Patricia Cowan, Donna Hathaway

Biological research for nursing 2016;17(4):413-21

Free Full Text

Abstract

Striatal dopamine D2-like receptors availability in obesity and its modulation by bariatric surgery: a systematic review and meta-analysis.

Gabriela Ribeiro, Ana Maia, Gonçalo Cotovio, Francisco P M Oliveira, Durval C Costa, Albino J Oliveira-Maia

Scientific reports 2023;13(1):4959

Free Full Text

Abstract

Dopamine receptor D2 polymorphism is associated with alleviation of obesity after 8-year follow-up: a retrospective cohort study in obese Chinese children and adolescents.

Jian-Fang Zhu, Lian-Hui Chen, Ke Yuan, Li Liang, Chun-Lin Wang

Journal of Zhejiang University. Science. B 2019;19(10):807-814

Free Full Text

Abstract

A meta-analysis of the relationship between brain dopamine receptors and obesity: a matter of changes in behavior rather than food addiction?

D Benton, H A Young

International journal of obesity (2005) 2016;40 Suppl 1(Suppl 1):S12-21

Free Full Text

Abstract

Structural Investigation of the Dopamine-2 Receptor Agonist Bromocriptine Binding to Dimeric D2R and D2R States.

Ramin Ekhteiari Salmas, Philip Seeman, Matthias Stein, Serdar Durdagi

Journal of chemical information and modeling 2019;58(4):826-836

Full Text

Abstract

Positron emission tomography in acromegaly and other pituitary adenoma patients.

Carin Muhr

Neuroendocrinology 2006;83(3-4):205-10

Full Text

Abstract

The Cys allele of the DRD2 Ser311Cys polymorphism has a dominant effect on risk for schizophrenia: evidence from fixed- and random-effects meta-analyses.

Stephen J Glatt, Erik G Jönsson

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2006;141B(2):149-54

Free Full Text

Abstract

Anatomical relationships between serotonin 5-HT2A and dopamine D2 receptors in living human brain.

Tatsuya Ishii, Yasuyuki Kimura, Masanori Ichise, Keisuke Takahata, Soichiro Kitamura, Sho Moriguchi, Manabu Kubota, Ming-Rong Zhang, Makiko Yamada, Makoto Higuchi, Yoshiro Okubo, Tetsuya Suhara

PloS one 2018;12(12):e0189318

Free Full Text

Abstract

Attention-deficit/hyperactivity disorder: is it time to reappraise the role of sugar consumption?

Richard J Johnson, Mark S Gold, David R Johnson, Takuji Ishimoto, Miguel A Lanaspa, Nancy R Zahniser, Nicole M Avena

Postgraduate medicine 2011;123(5):39-49

Free Full Text

Abstract

N-linked Glycosylation on the N-terminus of the dopamine D2 and D3 receptors determines receptor association with specific microdomains in the plasma membrane.

Chengchun Min, Mei Zheng, Xiaohan Zhang, Shuohan Guo, Kyoung-Ja Kwon, Chan Young Shin, Hyeong-Suk Kim, Seung Hoon Cheon, Kyeong-Man Kim

Biochimica et biophysica acta 2015;1853(1):41-51

Free Full Text

Abstract

Results: 1 – 15 / 84

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Receptors, Dopamine D2""[mesh_terms]

Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia: III. Retinoids.

Ligand with Two Modes of Interaction with the Dopamine D Receptor-An Induced-Fit Mechanism of Insurmountable Antagonism.

Common variants in DRD2 are associated with sleep duration: the CARe consortium.

Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome.

Selectivity of probes for PET imaging of dopamine D3 receptors.

Neurogenetic and Neuroimaging Evidence for a Conceptual Model of Dopaminergic Contributions to Obesity.

Striatal dopamine D2-like receptors availability in obesity and its modulation by bariatric surgery: a systematic review and meta-analysis.

Dopamine receptor D2 polymorphism is associated with alleviation of obesity after 8-year follow-up: a retrospective cohort study in obese Chinese children and adolescents.

A meta-analysis of the relationship between brain dopamine receptors and obesity: a matter of changes in behavior rather than food addiction?

Structural Investigation of the Dopamine-2 Receptor Agonist Bromocriptine Binding to Dimeric D2R and D2R States.

Positron emission tomography in acromegaly and other pituitary adenoma patients.

The Cys allele of the DRD2 Ser311Cys polymorphism has a dominant effect on risk for schizophrenia: evidence from fixed- and random-effects meta-analyses.

Anatomical relationships between serotonin 5-HT2A and dopamine D2 receptors in living human brain.

Attention-deficit/hyperactivity disorder: is it time to reappraise the role of sugar consumption?

N-linked Glycosylation on the N-terminus of the dopamine D2 and D3 receptors determines receptor association with specific microdomains in the plasma membrane.

Results for
""Receptors, Dopamine D2""[mesh_terms]